Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell LymphomaMichael Wang, Nirav N. Shah, Pier Luigi Zinzani et al.|Journal of Clinical Oncology|2023Cited by 106
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trialChanghee Park, Youngil Koh|Nature Communications|2024Cited by 10